Literature DB >> 24376986

The clinical importance of micrometastases within the lymphatic system in patients after total gastrectomy.

Arkadiusz Spychała1, Dawid Murawa1, Konstanty Korski2.   

Abstract

BACKGROUND: In spite of radical gastrectomy with resection of the lymphatic system, where no metastases are found during histopathological examination, about 30% of patients have relapse of the neoplastic process. This situation may be caused by micrometastases or isolated neoplastic cells in the lymphatic system which were not identified during a standard histopathological examination. AIM: The aim of the study was to evaluate the clinical importance of micrometastases within the lymphatic system in patients with gastric cancer.
MATERIALS AND METHODS: A group of 20 patients treated for gastric cancer were subjected to retrospective analysis. Of all the patients who underwent surgery, a group with tumours classified as T1 or T2 was selected. No metastases within the lymphatic system were found in the standard evaluation - N0 mark. Paraffin-embedded blocks of lymph nodes were cut and new specimens were made, which were then stained again by means of immunohistochemistry. Antibodies against cytokeratin AE1/AE3 were used.
RESULTS: A total of 319 lymph nodes were assessed in 20 patients in an H + E examination. After the immunohistochemical examination, micrometastases within the lymphatic system were found in 4 (20%) patients and isolated neoplastic cells in other 4 (20%) patients.
CONCLUSION: On the basis of numerous publications and our own material, we think that the presence of micrometastases may be related to a worse prognosis. The clinical importance of micrometastases within the lymphatic system in patients after total gastrectomy.

Entities:  

Keywords:  Gastric cancer; Isolated tumour cells; Micrometastases

Year:  2011        PMID: 24376986      PMCID: PMC3863198          DOI: 10.1016/j.rpor.2011.08.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  23 in total

Review 1.  Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.

Authors:  F De Vita; F Giuliani; N Silvestris; G Catalano; F Ciardiello; M Orditura
Journal:  Cancer Treat Rev       Date:  2010-11       Impact factor: 12.111

2.  Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer.

Authors:  A Nakajo; S Natsugoe; S Ishigami; M Matsumoto; S Nakashima; S Hokita; M Baba; S Takao; T Aikou
Journal:  Ann Surg Oncol       Date:  2001-03       Impact factor: 5.344

3.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

4.  Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer.

Authors:  Jianhui Cai; Masahide Ikeguchi; Michio Maeta; Nobuaki Kaibara; Takashi Sakatani
Journal:  Gastric Cancer       Date:  1999-08       Impact factor: 7.370

5.  Predictive value of genetic diagnosis for cancer micrometastasis: histologic and experimental appraisal.

Authors:  N Yamamoto; Y Kato; A Yanagisawa; H Ohta; T Takahashi; T Kitagawa
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

6.  Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.

Authors:  Anja Ulmer; Jörg R Fischer; Stefan Schanz; Karl Sotlar; Helmut Breuninger; Klaus Dietz; Gerhard Fierlbeck; Christoph A Klein
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

7.  The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.

Authors:  T Fukagawa; M Sasako; T Shimoda; T Sano; H Katai; M Saka; G B Mann; M Karpeh; D G Coit; M F Brennan
Journal:  Ann Surg Oncol       Date:  2009-01-10       Impact factor: 5.344

8.  Prediction of recurrence of early gastric cancer after curative resection.

Authors:  Ji Fu Lai; Sungsoo Kim; Kiyeol Kim; Chen Li; Sung Jin Oh; Woo Jin Hyung; Sun Young Rha; Hyun Cheol Chung; Seung Ho Choi; Lin Bo Wang; Sung Hoon Noh
Journal:  Ann Surg Oncol       Date:  2009-05-12       Impact factor: 5.344

9.  Impact of micrometastases in the sentinel node of patients with invasive breast cancer.

Authors:  Nora M Hansen; Baiba Grube; Xing Ye; Roderick R Turner; R James Brenner; Myung-Shin Sim; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry.

Authors:  H A Gietema; R J C L M Vuylsteke; I A de Jonge; P A M van Leeuwen; B G Molenkamp; J R M van der Sijp; S Meijer; P J van Diest
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  1 in total

1.  HMMR promotes peritoneal implantation of gastric cancer by increasing cell-cell interactions.

Authors:  Muwen Yang; Boyu Chen; Lingzhi Kong; Xiangfu Chen; Ying Ouyang; Jiewen Bai; Donglin Yu; Huizhong Zhang; Xinghua Li; Dongsheng Zhang
Journal:  Discov Oncol       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.